Drug Database · Clinicians

Xylometazoline

Brands (6) Zynasalo, Xytasaph, Armazoline…Show all

US brand (reference label): Metarivin Soln. 0.1%; not a Philippine-registered brand.

Nasal decongestant; Nasal drops decongestant; and others PH FDA category

Rx · Prescription drugOTC · Over-the-counter11 PH products
Dispensing: Over-the-counter (OTC) · Prescription (Rx) Last updated: Audience: Licensed health professionals
Label text on this page: US FDA-approved label via DailyMed/openFDA, set ID e9da6f39-8620-faca-e053-2995a90a8a57, version date September 30, 2022 (Metarivin Soln. 0.1% · Lydia Co., Ltd.). Reproduced verbatim. Philippine-approved indications and doses may differ: check the PH package insert.

Use: Labeled indications

  • Adults and children 7 years and older: Spray into the nose 3 times a day
US FDA label
Full indications and usage US FDA label

Adults and children 7 years and older: Spray into the nose 3 times a day

Dosing: Adult

Dosage and administration (US label) US FDA label

for nasal use

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Nasal solution: 1 mg/mL, 500 mcg/mL
  • Nasal spray: 10 mg/10 mL, 500 mcg/mL
  • Nasal spray solution: 1 mg/mL, 10 mg/10 mL
  • Nasal drops: 1 mg/mL

Registered products in the Philippines

11 products registered with the Food and Drug Administration (FDA) Philippines list Xylometazoline as the generic name (including products registered under a variant spelling). Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Also registered under: Xylometazoline HCI (1 product). Products registered under these spellings are included in the table and marked.

Verify on PH FDA portal

All registered products11
Philippine FDA-registered products for Xylometazoline
Package insert
ArmazolineXylometazoline HCIVariant spelling
1mg/mL Nasal SolutionHDPE Bottle x 15mL (Box of 1's)
OTC
Taiguk Pharma, Co., Ltd.Korea
Importer: H & B Pharma International Inc.
DRP-11213
Feb 15, 2027
NoneXylometazoline Hydrochloride
1 mg/mL (0.1% w/v) Nasal SolutionHDPE/LDPE Plastic Dropper Bottle x 10 mL (Box of 1's)
OTC
West-Coast Pharmaceutical Works Ltd.India
Actimed, Inc.Importer: Ambica International Corporation
DRP-6104-01
Apr 16, 2030
XylometXylometazoline hydrochloride
1 mg/mL (0.1%) Nasal Spray SolutionHDPE White Plastic Bottle x 15 mL
Rx
Lloyd Laboratories, Inc.Philippines
Trader: Nurturemed Pharma, Inc.
DR-XY38925
Jan 10, 2031
XylonasXylometazoline Hydrochloride
1 mg/mL (0.1% w/v) Nasal Solution (Drops)
OTC
Geofman Pharmaceuticals
Sahar International Trading Inc.
DR-XY40321
Nov 21, 2026
XyloneXylometazoline Hydrochloride
1 mg/mL (0.1% w/v) Nasal SolutionHDPE/LDPE plastic dropper bottle x 10 mL (Box of 1's)
OTC
West-Coast Pharmaceutical Works Ltd.India
Scheeling, Inc.Importer: Ambica International Corporation
DRP-6104
Apr 16, 2030
XytasaphXylometazoline hydrochloride
1 mg/mL (0.10% w/v) Nasal DropsWhite HDPE Plastic Dropper Bottle x 10 mL and 15 mL (Box of 1's)
OTC
Kilitch Drugs (India) Ltd.India
Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd.
DRP-14080
Jun 16, 2028
XytasaphXylometazoline hydrochloride
500 mcg/mL (0.05% w/v) Nasal Solution (Drops)White HDPE Plastic Dropper Bottle x 10 mL and 15 mL (Box of 1's)
OTC
Kilitch Drugs (India) Ltd.India
Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd.
DRP-14079
Jun 16, 2028
ZynasaloXylometazoline Hydrochloride
10 mg/10mL (0.1% w/v) Nasal Spray SolutionLDPE nasal bottle 10mL box of 1's
OTC
Ebe Pharmaceutical Co., Ltd.China
Aglobal Care, Inc.
DRP-12570
Sep 12, 2027
ZynasaloXylometazoline Hydrochloride
10 mg/10mL Nasal Spray10 mL LDPE Nasal Spray Bottle (Box of 1's)
OTC
Ebe Pharmaceutical Co., Ltd.China
Aglobal Care, Inc.
DRP-13362
Feb 3, 2028
ZynasaloXylometazoline (as Hydrochloride)
500 mcg/mL (0.05 % w/v) Nasal Solution (Drops)LDPE Plastic Bottle x 10 mL (Box of 1's)
OTC
EBE PHARMACEUTICAL CO., LTD.China
Aglobal Care, Inc.
DRP-14212
Jul 27, 2028
ZynasaloXylometazoline (as Hydrochloride)
500 mcg/mL (0.05 % w/v) Nasal SprayHDPE Spray Bottle x 10 mL (Box of 1's)
OTC
EBE PHARMACEUTICAL CO., LTD.China
Aglobal Care, Inc.
DRP-14213
Jul 27, 2028

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Warnings/Precautions

Warnings and precautions (US label) US FDA label

■ When using this product Stop use and ask a doctor if nervousness, diziness, or sleepness occur. Pain, nasal congestion or cough gets worse or lasts more than 7 days. fever gets worse or lasts more than 3 days New symtoms occur. keep out of reach of children. In case of overdose, get medical help or contact a poison contral center right away. If pregnant or breast-feeding, ask a health professional before use.

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. U.S. Food and Drug Administration. Metarivin Soln. 0.1% · Lydia Co., Ltd. [US FDA-approved label, version 2, September 30, 2022]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e9da6f39-8620-faca-e053-2995a90a8a57
  2. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .